Due to absence of physical inflammation and negative culture results, it may be difficult to differentiate low-grade prosthetic infections from aseptic loosening ([@CIT0009], [@CIT0019], [@CIT0012]). To allow accurate diagnosis in such cases, molecular methods such as polymerase chain reaction (PCR)-based assays and histopathological examination should be combined ([@CIT0001]). Thus, determination of the correct sampling region---in broad terms, whether it is on the acetabular side or the femoral side in total hip arthroplasty (THA) patients---is important.

The aim of the present study was not to differentiate septic from aseptic loosening using ^18^F-fluoride positron emission tomography (PET), but to determine whether the results of tissue examinations in THA patients are affected by the sampling location, classified as major, minor, or no-uptake sides in terms of ^18^F-fluoride uptake.

Patients and methods {#ss1}
====================

This prospective study was approved by the institutional review board of Yokohama City University Hospital (01-08-2006, No 204). A consecutive series of 41 THA patients experiencing pain (43 hips) and 17 THA patients with no complications (23 hips) who gave informed consent were investigated with ^18^F-fluoride PET between 2006 and 2010. 23 of the 41 THA patients experiencing pain (23 of 43 hips), with a mean age of 73 (56--89) years, who were scheduled to undergo revision surgery were classified as the revision group and were enrolled in the study. To determine the normal range of ^18^F-fluoride uptake values, 17 pain-free THA patients (23 hips) with a mean age of 68 (32--74) years and with no evidence of loosening from radiographic, serological, or physical examination were enrolled as the control group. The mean time after primary surgery was 14 (2--28) years in the revision group and 7 (2--20) years in the control group. The control group was followed for mean 2.2 (1--3) years after fluoride PET scanning by regular physical, radiographic, and serological examinations.

The pattern of ^18^F-fluoride PET uptake was classified into 3 categories: major uptake, minor uptake, and no uptake, using the following definitions ([Figure 1](#F1){ref-type="fig"}). An SUV~max~ of \> 5 covering more than 50% of the implant was defined as major uptake. An SUV~max~ of \>5 covering less than 50% of the implant was defined as minor uptake. When the SUV~max~ was less than 5, this was defined as no uptake. The same criteria were applied to the acetabular side and the femoral side.

![Definitions used for the ^18^F-fluoride PET uptake patterns on the acetabular and femoral sides. A. Major-uptake region on the acetabular side: ^18^F-fluoride uptake has spread to more than 50% of the acetabular component with an SUV~max~ of \> 5. B. Minor-uptake region on the acetabular side: ^18^F-fluoride uptake has localized in less than 50% of the acetabular component with an SUV~max~ of \> 5. C. Major-uptake region on the femoral side: ^18^F-fluoride uptake has spread to more than 50% of the femoral component with an SUV~max~ of \> 5. D. Minor-uptake region on the femoral side: ^18^F-fluoride uptake has localized in less than 50% of the femoral component with an SUV~max~ of \> 5.](ORT-0300-9734-082-427_g001){#F1}

PET scanning {#ss2}
------------

PET images were obtained using a SET 2400 W machine (Shimadzu, Kyoto, Japan) equipped with 20.0-cm and 59.5-cm transverse fields of view and producing 63 image planes with a 3.125-mm interval. The transverse resolution at the center of view was 4.2 mm, and the full width-half maximum was 5.0 mm. A whole-body image was obtained 40 min after the injection of 185 MBq ^18^F-fluoride in 10 mL of 0.9% saline solution using the multiple-bed position technique. 4 to 5 sections from the head to the thigh were imaged. Attenuation-corrected transverse images were reconstructed using the ordered-subsets expectation maximization algorithm into 128 × 128 matrices with pixel dimensions of 4.0 mm in-plane and 3.125 mm axially. Coronal images with a 9.8-mm section thickness were also reconstructed from attenuation-corrected transverse images for visual interpretation ([@CIT0018]).

The maximal standardized uptake value (SUV~max~) was measured axially on the acetabular and femoral sides of each joint by 2 investigators, and the higher of the measurements was used. We then compared these values in the revision group and the control group. Statistical analysis was performed using the unpaired t-test and a p-value of less than 0.01 was considered to be significant.

Diagnosis of infection in the current study {#ss3}
-------------------------------------------

A definitive diagnosis of infection was made from the evaluation of intraoperative specimens obtained from both the acetabular and femoral sides in all patients in the revision group. These tissue samples were evaluated by histopathological examination, microbiological culture, and real-time PCR for the detection of bacterial DNA. When at least 1 of these 3 examinations showed a positive finding, a definitive diagnosis of periprosthetic infection was made. To obtain consistency between the ^18^F-fluoride uptake and intraoperative results, the sensitivity of these intraoperative results on the ^18^F-fluoride major-uptake, minor-uptake, and no-uptake sides were calculated separately.

Histopathological examination {#ss4}
-----------------------------

Frozen sections were used to establish an rapid diagnosis intraoperatively, and permanent sections were used for diagnosis postoperatively. Infiltration of 10 or more neutrophils per high-power field (400× magnification, with a field diameter of 0.6 mm) was defined as acute inflammation, and was considered to be suggestive of infection ([@CIT0011]).

Microbiological culture {#ss5}
-----------------------

All specimens were processed using standard microbiological culture (aerobic and anaerobic), and bacteria were allowed to grow for up to 7 days using Nissui Tube Gifu anaerobic medium (GAM) (Nissui Pharmaceutical, Tokyo, Japan), which was semi-solid. A VITEK 2 compact device (bioMérieux, Inc., Durham, NC) was used for automated identification of microorganisms in accordance with the manufacturer\'s instructions.

Real-time PCR {#ss6}
-------------

Bacterial DNA was extracted from the intraoperative tissues using a Qiagen DNA mini kit (Qiagen, Valencia, CA) and then analyzed by quantitative real-time PCR using the Light Cycler 2.0 system (Roche Diagnostics GmbH, Mannheim, Germany). 2 different primer and probe sets were used: methicillin-resistant staphylococcus (MRS) PCR using a methicillin-resistant Staphylococcus aureus (MRSA) detection kit (Roche Diagnostics GmbH, Mannheim, Germany) and broad-range universal PCR, as previously described ([@CIT0008], [@CIT0010]). The same program settings were used in both cases: an initial hot start at 95°C for 10 min, followed by 45 cycles at 95°C for 10 seconds, 55°C for 10 seconds, and 72°C for 12 seconds.

Results {#ss7}
=======

Major-uptake regions were found in 17 patients in the revision group---on the acetabular side or the femoral side, or both---and a definitive infection was confirmed in each of these 17 patients. The 6 remaining patients in the revision group showed minor-uptake regions on one or both sides, and no infections were diagnosed in these patients ([Table 1](#T1){ref-type="table"}).

###### 

Results of PET, histopathological examination, microbiological culture, and real-time PCR in the revision group

                ^18^F--fluoride PET   Postoperative diagnosis from intraoperative specimens                                    
  ---- ---- --- --------------------- ------------------------------------------------------- ---------- --------- ----------- -----------------------------------------
   1   75   F   5.1 / 6.7             Major / Major                                           \+ / --    \+ / +    \+ / +      *Staphylococcus hominis--hominis* (MRS)
   2   73   F   5.1 / 3.1             Major / --                                              \+ / --    -- / --   \+ / +      Negative
   3   65   M   9.1 / 2.5             Major / --                                              \+ / --    \+ / --   \+ / --     MRSE
   4   73   F   8.6 / 4.9             Major / --                                              \+ / --    \+ / --   \+ / +      MRSE
   5   65   M   5.6 / 13              Minor / Major                                           -- / N/A   -- / --   -- / +      Negative
   6   63   F   7.7 / 10              Minor / Major                                           -- / +     -- / --   \+ / +      *Streptococcus agalactiae*
   7   75   M   11 / 12               Major / Major                                           \+ / +     \+ / +    \+ / +      *Staphylococcus auricularis* (MRS)
   8   77   F   17 / 3.5              Major / --                                              \+ / --    -- / --   \+ / --     Negative
   9   65   M   6.8 / 9.8             Minor / Major                                           -- / --    -- / --   -- / +      Negative
  10   71   F   10 / 11               Major / Major                                           -- / +     -- / --   -- / +      Negative
  11   70   M   12 / 10               Major / Major                                           \+ / +     \+ / +    \+ / +      Non--hemolytic streptococcus
  12   56   F   9.8 / 6.1             Major / Minor                                           \+ / --    -- / --   N/A / N/A   Negative
  13   89   M   5.8 / 6.8             Major / Major                                           \+ / +     \+ / +    \+ / +      *Streptococcus sanguinis*
  14   70   F   14 / 2.3              Major / --                                              -- / --    \+ / --   \+ / --     *Staphylococcus warneri*
  15   82   F   9.0/13                Major / Major                                           -- / +     \+ / --   \+ / +      Aerobic Gram--positive bacillus
  16   83   F   15 / 11               Major / Minor                                           \+ / --    -- / --   \+ / --     Negative
  17   69   F   6.8 / 14              Major / Major                                           \+ / +     \+ / +    \+ / +      MRSE
  18   78   M   5.2 / 2.3             Minor / --                                              -- / --    -- / --   -- / --     Negative
  19   69   F   6.8 / 2.3             Minor / --                                              -- / --    -- / --   -- / --     Negative
  20   59   M   2.8 / 9.0             -- / Minor                                              -- / --    -- / --   -- / --     Negative
  21   83   M   1.7 / 6.2             -- / Minor                                              -- / --    -- / --   -- / --     Negative
  22   83   F   9.9 / 4.5             Minor / --                                              -- / --    -- / --   -- / --     Negative
  23   73   M   7.4 / 3.3             Minor / --                                              -- / --    -- / --   -- / --     Negative

N/A: not available.

A Case

B Age

C Sex

D SUV ~max~ (acetabular/femoral)

E Uptake pattern (acetabular/femoral)

F Histopathological examination (acetabular/femoral)

G Microbiological culture (acetabular/femoral)

H Real-time PCR (acetabular/femoral)

I Bacterial strain

In the control group, minor-uptake regions were observed in 3 patients but no major-uptake regions were found in any of these patients. In addition, none of the control patients showed any evidence of infection or loosening in radiographic, serological, or physical examinations during the follow-up period.

The mean SUV~max~ of the septic loosening patients was 11 (5--17) and that of the 6 aseptic loosening patients was 7 (5--10). The mean SUV~max~ of the control group was 4 (3--6). The overall differences between the septic loosening patients and the control group, and also between the aseptic loosening patients and the control group in terms of the SUV~max~ were statistically significant (p \< 0.001 and p \< 0.01, respectively).

Major-uptake regions were found on 24 sides in 17 patients (14 sides on the acetabular side and 10 sides on the femoral side). Definitive infection was found in 23 of the 24 sides with major uptake. The sensitivity of the 3 methods for diagnosis of infection was calculated separately for major-, minor-, and no-uptake sides in the revision group: 0.78, 0.58, 0.96, respectively, and in combination (0.96). In contrast, the corresponding sensitivities of these tests for the minor-uptake sides were 0.00, 0.00, 0.10, and 0.10, and for the no-uptake sides they were 0.00, 0.00, 0.18, and 0.18, respectively ([Table 2](#T2){ref-type="table"}). [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} show representative ^18^F-fluoride images in septic loosening cases and [Figure 4](#F4){ref-type="fig"} shows representative ^18^F-fluoride images in aseptic loosening cases

###### 

The sensitivity of histopathological examination, microbiological culture, and real-time PCR---individually and in combination---in analyzing the ^18^F-fluoride major-, minor- and no-uptake sides in the revision group

                                  On major-uptake side (24 sides)   On minor-uptake side (11 sides)   On no-uptake side (11 sides)
  ------------------------------- --------------------------------- --------------------------------- ------------------------------
  Histopathological examination                                                                       
   Positive                       18                                0                                 0
   Negative                       5                                 11                                11
   Side not available             1                                 --                                --
   Sensitivity                    0.78                              0                                 0
  Microbiological culture                                                                             
   Positive                       14                                0                                 0
   Negative                       10                                11                                11
   Sensitivity                    0.58                              0                                 0
  Real-time PCR                                                                                       
   Positive                       22                                1                                 2
   Negative                       1                                 9                                 9
   Side not available             1                                 1                                 --
   Sensitivity                    0.96                              0.1                               0.18
  Combined                                                                                            
   Positive                       23                                1                                 2
   Negative                       1                                 10                                9
   Sensitivity                    0.96                              0.1                               0.18

![A. Patient no. 5 (revision group) with a radiolucent line around the femoral implant. B. ^18^F-fluoride PET image showing minor uptake with an SUV~max~ of 5.6 on the acetabular side and major uptake with an SUV~max~ of 13 on the femoral side. In this patient, real-time PCR was positive only for tissues sampled from the femoral side, suggesting the existence of localized infection around the femoral component.](ORT-0300-9734-082-427_g002){#F2}

![A. Patient no. 8 (revision group) with severe loosening of the cup side. B. ^18^F-fluoride PET image. Massive ^18^F-fluoride uptake on the acetabular side suggested that the focal point of inflammation was localized around the acetabular component. The SUV~max~ was 17 on the acetabular side (white arrow) and 3.5 on the femoral side, indicating major uptake only on the acetabular side. C. Histopathological examination indicated infection with a minimum of 5 HPF (×400) containing 10 or more neutrophils. In this patient, the histopathological examination and real-time PCR results were both positive only for tissues sampled from the acetabular side, suggesting the existence of localized infection on the membrane around the acetabular component.](ORT-0300-9734-082-427_g003){#F3}

![A. Patient no. 22 (revision group) with a horizontally-moved acetabular implant. B. ^18^F-fluoride PET axial image showing a minor-uptake region with an SUV~max~ of 9.9 on the acetabular side. C. ^18^F-fluoride PET coronal image showing a minor-uptake region on the acetabular side and a no-uptake region with an SUV~max~ of 4.5 on the femoral side. This patient was diagnosed as having aseptic loosening, as no positive results were obtained in any of the tissue examinations](ORT-0300-9734-082-427_g004){#F4}

Discussion {#ss8}
==========

A robust diagnosis of periprosthetic infection requires that a combination of testing methods should be undertaken ([@CIT0019]). It must be noted that the accuracy of all diagnostic tests is limited by the appropriateness of the tissue sampling. In other words, if intraoperative tissue specimens are collected from an uninfected site, false-negative results will be obtained. We found that sampling of intraoperative tissues to establish a definitive diagnosis of infection after THA should be from the ^18^F-fluoride major-uptake side to give reliable results.

^99m^Tc-labeled bone scintigraphy, which is regarded as having a dynamic capacity similar to that of ^18^F-fluoride to provide bone remodeling data, is also a useful test for the diagnosis of periprosthetic complications of the hip ([@CIT0005]). Using a time-difference radioisotope uptake technique, a triple-phase bone scanning protocol can be useful for diagnosing periprosthetic infection with a sensitivity of 88% and a specificity of 90% ([@CIT0013]). ^18^F-fluorodeoxy glucose (FDG)-PET is one of the best known of these imaging technologies, and it has been applied extensively to the diagnosis of periprosthetic infections of the hip ([@CIT0020], [@CIT0015], [@CIT0004], [@CIT0014], [@CIT0016], [@CIT0003]). [@CIT0003] have emphasized that optimal diagnostic criteria can differentiate septic loosening from aseptic loosening at a hip prosthesis with 85% sensitivity and a specificity of 93%. However, the reliability of this in discriminating between aseptic and septic inflammation remains controversial ([@CIT0002], [@CIT0017], [@CIT0004]).

^18^F-fluoride is a well-established positron-emitting bone-seeking agent, and its uptake reflects both blood flow and remodeling of bone. With the recent improvements in imaging efficiency, ^18^F-fluoride PET has been recognized for its usefulness in diagnosing the regional characterization of skeletal disorders such as malignant and benign skeletal legio lesion, bone metastasis, or Paget\'s disease ([@CIT0007], [@CIT0006]). However, there have been no reports to date of the use of ^18^F-fluoride PET imaging in cases of periprosthetic infection. Although our patient series was not large, our findings strongly suggest that major uptake of ^18^F-fluoride periprosthetically in THA cases is of value in determining the correct tissue sampling side and in giving the possibility of preserving the implant on another side. However, it is still unclear whether the use of ^18^F-fluoride improves the sensitivity and specificity regarding differentiation of septic loosening from aseptic loosening, and more clinical cases will have to be evaluated in future in order to confirm its usefulness.

One limitation of the present study is the small number of cases of aseptic loosening in the patient cohort. We were therefore unable to calculate the sensitivity and specificity of ^18^F-fluoride PET for the diagnosis of septic loosening as described above. However, ^18^F-fluoride PET was found to be diagnostically useful in cases of periprosthetic infection, with no false positives arising in our aseptic loosening cases or in the control group, and no false negatives observed in the cases of septic loosening.
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